Press Release: Columbia University : Alaya.bio Expands in situ CAR-T Therapy Collaboration with Michel Sadelain and Columbia University

NEW YORK--(BUSINESS WIRE)-- Alaya.bio, a biotechnology company developing a scalable polymeric delivery platform to precisely target and reprogram cells in situ, is pleased to announce an expanded collaboration with Michel...